CP

Caligan Partners Portfolio holdings

AUM $515M
1-Year Est. Return 70.09%
This Quarter Est. Return
1 Year Est. Return
+70.09%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$515M
AUM Growth
+$35.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
18
New
Increased
Reduced
Closed

Top Buys

1
+$14.7M
2
+$12.3M
3
+$6.32M
4
RZLT icon
Rezolute
RZLT
+$6.25M
5
EOLS icon
Evolus
EOLS
+$5.63M

Top Sells

1
+$24.3M
2
+$22.1M
3
+$1.79M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNA
1
DELISTED
Verona Pharma
VRNA
$136M 26.13%
1,436,878
LQDA icon
2
Liquidia Corp
LQDA
$1.94B
$101M 19.45%
8,118,892
+300
EXEL icon
3
Exelixis
EXEL
$10.6B
$67.2M 12.93%
1,525,730
AGIO icon
4
Agios Pharmaceuticals
AGIO
$2.46B
$35.6M 6.85%
1,071,258
+369,978
MRUS icon
5
Merus
MRUS
$7.19B
$34.6M 6.64%
656,999
+280,045
EOLS icon
6
Evolus
EOLS
$414M
$30.8M 5.92%
3,341,970
+610,816
MLYS icon
7
Mineralys Therapeutics
MLYS
$3.38B
$27.3M 5.25%
2,017,352
-132,315
RVMD icon
8
Revolution Medicines
RVMD
$10.1B
$23.4M 4.5%
636,835
+171,835
ANIK icon
9
Anika Therapeutics
ANIK
$132M
$15.2M 2.92%
1,435,130
ABVX
10
Abivax
ABVX
$7.22B
$12.8M 2.46%
1,674,400
+405,281
YMAB
11
DELISTED
Y-mAbs Therapeutics
YMAB
$10.6M 2.03%
2,342,609
RZLT icon
12
Rezolute
RZLT
$789M
$6.88M 1.32%
1,543,014
+1,401,705
BCRX icon
13
BioCryst Pharmaceuticals
BCRX
$1.4B
$5.72M 1.1%
638,908
-2,468,761
VRCA icon
14
Verrica Pharmaceuticals
VRCA
$39.2M
$4.9M 0.94%
923,912
+24,617
TYRA icon
15
Tyra Biosciences
TYRA
$773M
$1.82M 0.35%
189,950
+164,950
AURA icon
16
Aura Biosciences
AURA
$352M
$1.25M 0.24%
+200,000
SAGE
17
DELISTED
Sage Therapeutics
SAGE
– –
-3,052,538
SLS icon
18
SELLAS Life Sciences
SLS
$267M
– –
0